Hypertension, Vol 8, 30-36, Copyright © 1986 by American Heart Association
SC Hunt, RR Williams, JB Smith and KO Ash
To investigate the pathophysiology of essential hypertension, detailed
biochemical and clinical variables were collected and analyzed for 2091
Utah subjects aged 3 to 83 years. Three different measurements of
erythrocyte cation transport were obtained: Na+-Li+ countertransport,
Li+-K+ cotransport, and furosemide-insensitive Li+ efflux into MgCl2. Total
plasma cholesterol, triglycerides, and high density lipoprotein cholesterol
levels were obtained from fasting subjects. Levels of high density
lipoprotein subfractions 2 and 3 were also obtained from 350 subjects.
Standardized data collection also included blood pressure, height, weight,
and presence or absence of a diagnosis or treatment of essential
hypertension. In univariate analyses of all 1420 adults, each of the three
transport systems showed the same significant correlations with
triglyceride levels (r = 0.33-0.35, p less than 0.0001), high density
lipoprotein concentration (r = -0.19 to -0.21, p less than 0.001), and
weight (r = 0.22-0.28, p less than 0.0001). In multivariate regression
analyses, values for each transport system were significantly higher in
hypertensive subjects; values for triglycerides, high density lipoprotein,
and usually, the high density lipoprotein subfractions continued to have
strong significant independent associations with all three transport
systems; and weight remained significantly related only to Na+-Li+
countertransport. In separate logistic regressions, plasma triglyceride
levels (positively, p less than 0.001) and high density lipoprotein
subfraction 3 levels (inversely, p less than 0.03) were associated with
hypertension itself. In multivariate analyses among 671 children, high
density lipoprotein and high density lipoprotein subfraction 3 levels
showed significant (p less than 0.05) inverse correlations with Na+-Li+
countertransport and furosemide-insensitive Li+ efflux.(ABSTRACT TRUNCATED
AT 250 WORDS)
ARTICLES
Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects
This article has been cited by other articles:
![]() |
C. G. Savopoulos, A. I. Hatzitolios, N. A. Katsiki, M. Baltatzi, M. Kosmidou, N. Raikos, D. P. Mikhailidis, A. G. Ziakas, G. Kaiafa, and N. Tsesmeli Sodium-Lithium Countertransport Activity in Healthy, Dyslipidemic, and Hypertensive Individuals Angiology, January 1, 2009; 59(6): 727 - 735. [Abstract] [PDF] |
||||
![]() |
A. B. Weder, M. C. Delgado, X. Zhu, L. Gleiberman, D. Kan, and A. Chakravarti Erythrocyte Sodium-Lithium Countertransport and Blood Pressure: A Genome-Wide Linkage Study Hypertension, March 1, 2003; 41(3): 842 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Schork, J. P. Gardner, L. Zhang, D. Fallin, B. Thiel, H. Jakubowski, and A. Aviv Genomic Association/Linkage of Sodium Lithium Countertransport in CEPH Pedigrees Hypertension, November 1, 2002; 40(5): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mead, R. Wilkinson, and T. H. Thomas Thiol Protein Defect in Sodium-Lithium Countertransport in Subset of Essential Hypertension Hypertension, December 1, 1999; 34(6): 1275 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zicha, Z. Dobesova, and J. Kunes Plasma Triglycerides and Red Cell Ion Transport Alterations in Genetically Hypertensive Rats Hypertension, September 1, 1997; 30(3): 636 - 640. [Abstract] [Full Text] |
||||
![]() |
M. Laurenzi, M. Cirillo, W. Panarelli, M. Trevisan, R. Stamler, A. R. Dyer, and J. Stamler Baseline Sodium-Lithium Countertransport and 6-Year Incidence of Hypertension: The Gubbio Population Study Circulation, February 4, 1997; 95(3): 581 - 587. [Abstract] [Full Text] |
||||
![]() |
Y. Chi, D. M. de Freitas, M. Sikora, and V. K. Bansal Correlations of Na+-Li+ Exchange Activity With Na+ and Li+ Binding and Phospholipid Composition in Erythrocyte Membranes of White Hypertensive and Normotensive Individuals : A Nuclear Magnetic Resonance Investigation Hypertension, March 1, 1996; 27(3): 456 - 464. [Abstract] [Full Text] |
||||
![]() |
O. Giampietro, E. Matteucci, G. Catapano, G. Dell'Omo, L. Talarico, C. Di Muro, V. Di Bello, and R. Pedrinelli Microalbuminuria and Erythrocyte Sodium-Hydrogen Exchange in Essential Hypertension Hypertension, May 1, 1995; 25(5): 981 - 985. [Abstract] [Full Text] |
||||
![]() |
D. M. Cummings, P. Amadio Jr, L. Nelson, and J. M. Fitzgerald The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension Arch Intern Med, February 1, 1991; 151(2): 250 - 259. [Abstract] [PDF] |
||||
![]() |
R. R. Williams, S. C. Hunt, P. N. Hopkins, B. M. Stults, L. L. Wu, S. J. Hasstedt, G. K. Barlow, S. H. Stephenson, J.-M. Lalouel, and H. Kuida Familial Dyslipidemic Hypertension: Evidence From 58 Utah Families for a Syndrome Present in Approximately 12% of Patients With Essential Hypertension JAMA, June 24, 1988; 259(24): 3579 - 3586. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |